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The direct endothelial contact with adjacent astrocytic end-feet is believed to establish blood-
brain barrier (BBB) typical characteristics in endothelial cells of the central nervous system 
(CNS). However, this contact is only present in capillary vessels of the brain parenchyma 
and absent in larger veins, arteries and vessels within the meninges. To investigate a 
potential impact of direct endothelial interactions with adjacent astrocytic end-feet on the 
molecular tight junction (TJ) composition and ultrastructure, we performed a systematic 
analysis of endothelial cell contacts within the vascular tree of parenchymal and 
leptomeningeal vessels. Immunofluorescence labeling for claudin-3, claudin-5, zonula 
occludens-1 and occludin was used to compare the molecular composition, without showing 
significant differences in their distribution along the vascular tree of parenchymal and 
leptomeningeal vessels. Furthermore, electron microscopy in combination with quantitative 
analyses was performed to investigate the endothelial ultrastructure revealing significant 
differences within the length of endothelial overlaps between the different vessel types. Here, 
parenchymal arteries exhibit noticeably longer cell contacts compared to capillaries, which 
could not be observed in leptomeningeal vessels. It was also observed that arterial vessels 
regularly contain a higher density of endothelial vesicles throughout the parenchyma and 
meninges as a sign for transendothelial traffic. Hence, endothelial expression of blood-brain 
barrier typical TJs is not limited to capillary vessels with an intimate contact to surrounding 
astrocytes, but is also observed in arteries and veins of the brain parenchyma as well as the 
meninges, the latter of which are lacking a direct astrocyte-endothelial interaction. These 
vessel-specific characteristics can now be used to address and compare alterations of the 
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1.  Introduction 
1.1  The blood-brain barrier 
 
The blood-brain barrier (BBB) limits and regulates molecular exchange at the interfaces 
between the blood and the neural tissue. This selective barrier is formed by overlapping 
endothelial cells that line all cerebral vessels (Begley and Brightman, 2003; Engelhardt and 
Sorokin, 2009). Together they act as a ‘physical barrier’ due to specific sealing complexes, 
the tight junctions (TJ). Thus, adjacent endothelial cells are tightly connected to restrict 
paracellular transport. Therefore most of the molecular traffic is forced to take a controlled 
transcellular passage across the BBB as its unique feature (Wolburg and Lippoldt, 2002a). 
An unrestricted passage is only guaranteed for small gaseous molecules such as O2 and 
CO2 thanks to their capability to diffuse freely through lipid membranes. Similar passing 
strategies are used by small lipophilic agents like ethanol to gain excess to the brain. 
However, in general, specific transport systems regulate all entering and exiting processes 
over the BBB. This logistic task is accomplished by the presence of luminal and abluminal 
membrane transportation systems to create a particular passage. Hence transportation of 
required nutrients can be facilitated, while at the same time harmful aggregates can be 
forcefully discharged. Additionally, the second line of restriction is provided by intracellular 
and extracellular enzymes like peptidases and P450 cytochromes, which metabolize and 
process compounds to change their activation state or function (el-Bacha and Minn, 1999). 
Large hydrophilic proteins are almost excluded from passing the BBB unless a specific 
receptor-mediated transport is available(Pardridge, 2003). However, the brain endothelium is 
known to have a lower density of intraendothelial vesicles supporting not only a restricted but 
also low activity of endocytosis/transcytosis transportation compared to peripheral 
endothelium(Reese and Karnovsky, 1967).  
To this point, the majority of the studies regarding the BBB have been focused only on the 
brain capillary endothelium, due to their simple structure and functional importance 
representing the largest surface area for blood-brain exchange. However, comparable 
structural and functional properties could also be found in the endothelium of vessels with 
larger diameters and additional cell layers like arterioles and venules (Ge et al., 2005). 
Although the term ‘blood–brain barrier’ rather implies an absolute barrier, the functional 
structure covers a range of passive and active features of the brain endothelium, which 
remain only partially understood. Thereby, the BBB still represents a fruitful target for further 





1.2 History  
 
The phenomenon of a BBB was first observed by Paul Ehrlich (Ehrlich, 1885), who noticed 
that that intravenously injected intravital dyes did not stain parenchymal brain tissue. 
Together with his fellow's observation by Lewandowski (Lewandowski, 1900) and Goldmann 
(Goldmann, 1913) who specified those preliminary findings by intrathecal applications of 
dyes and other substances to conclude some kind of existing barrier function between brain 
tissue and peripheral blood. For half a century, the structural equivalent of the barrier 
function remained unknown. With technical advantages and the development of electron 
microscopy in the 1960s intravenously injected tracers could be finally detected at the level 
of the vascular endothelium in the brain without passage into the parenchyma (Clawson et 
al., 1966; Donahue, 1964; Lampert and Carpenter, 1965). From that time point, more and 
more details were discovered as Reese and Karnovsky postulated that the physical 
restriction for the applied tracers to cross the BBB is generated by endothelial tight junctions 
(Brightman and Reese, 1969a; Reese and Karnovsky, 1967). Those intercellular sealing 
complexes were found to be highly expressed within the endothelium of brain capillaries and 
somehow restrict paracellular passage of applied tracers. Hence the tight junctions were 
thought to be impervious, thereby serving as a unique diffusion barrier for the brain 
(Farquhar and Palade, 1963). Initially, these sealing contacts were investigated exclusively 
by employing morphological methods with electron microscopy. In the 1980ies a switch 
towards the molecular understanding of the TJs was established to step by step unravel the 
composition of these complexes. Until today more and more components of the structural 
puzzle are found leaving a multitude of molecules involved in the establishment of BBB 
typical TJs with a detailed understanding of this molecular network forming the transcellular 
barrier. In contrast to a well-established understanding of epithelial barriers, endothelial cell 
contacts are far more complex and complicated (Brightman and Reese, 1969; Vorbrodt and 
Dobrogowska, 2003). Whereas epithelial cells develop barrier properties in vitro even in 
isolated monocultures, endothelial cells seem to need a great variety of environmental 
impact to mimic their in vivo properties in culture. In conclusion, the contribution of the brain-
specific microenvironment is crucial for endothelial tight junction formation (Abbott et al., 








1.3  Structure and composition 
 
Exclusively for the brain microvasculature is the ensheathment by a wall of astrocyte end-
feet and a leptomeningeal cell layer. On the ultrastructural level, two basement membranes 
are inherent for the brain microvasculature. First one is the endothelial basement membrane 
on the apical side. And secondly, the underlying astrocytic basement membrane composed 
of glial end-feet also known as the glia limitans. Additionally, a leptomeningeal cell sheet 
follows entering vessels from the parenchymal surface adding an additional layer in non-
capillary vessels (ALCOLADO et al., 1988; E. T. Zhang et al., 1990). The unique structural 
composition of the BBB differs between vessel types. Hence capillaries and postcapillary 
venules consist only of an endothelial monolayer intimately connected by tight junction 
complexes, whereas vessels with larger diameters like arterioles and arteries are built of 
multiple cell layers including pericytes and smooth muscle cells (Figure 1).    
 
Figure 1: A schematic and electron microscopy example presenting the three main vessel types, A the capillaries, 
B the veins, and C the arteries. Whereas the inner orange cells represent the endothelium, green additional 
smooth muscle cells or pericytes, in yellow the perivascular space (PVS) and blue the ensheathment by the glia 
limitans.  Clearly, showing significant differences in overall structure and composition especially regarding the 
distance between the astrocyte end-feet of the glia limitans and the endothelium. 
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Tight junctions connect adjacent endothelial cells. Their composition has been intensively 
studied to reveal the molecular composition (Figure 2). Hence, tissue-specific variations of 
the tight junction complexes were discovered. Unique to the TJ-sealed brain endothelium is a 
more complex structure shown by freeze-fracture analyses, which is shown to occlude the 
intercellular space more effectively (Wolburg and Lippoldt, 2002b). Each tight junction of the 
BBB is composed of selected transmembrane and cytoplasmic proteins. Occludin was the 
first descripted transmembrane protein located within tight junction complexes, which is 
generally found in endothelia and epithethelia throughout the body, but with the most intense 
expression observed in the brain (Furuse et al., 1993). In contrast, individual proteins of the 
claudin–family, are differently expressed between tissues and locations, with claudin-3 and 
claudin-5 being detectable in endothelial tight junctions of the BBB (Engelhardt and Sorokin, 
2009), whereas TJ within the liver are lacking a specific claudin-3 signal (Hanske et al., 
2017). Together with a third transmembrane family, the junctional adhesion molecule (JAM)-
A, are tight junction complexes connected to the actin cytoskeleton via cytoplasmic proteins 
to allow dynamic changes (Martìn-Padura et al., 1998; Wolburg and Lippoldt, 2002b). Such 
cytoplasmic proteins comprise proteins of the zonula occludens group (ZO-1, ZO-2, ZO-3) 
(Wolburg et al., 2002, Wolburg et al.,2001). Endothelial cell contacts have been shown to 
participate in controlling vascular permeability outside the central nervous system long before 
(Dejana et al., 2009).  However, recent studies are now demonstrating similar regulatory 
function in BBB homeostasis (Taddei et al., 2008,Artus et al., 2014; Liebner et al., 2008). 
 
Figure 2: Schematic drawing displaying TJ molecular composition (from Dyrna et al., 2013)  
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1.4  The role of the microenvironment  
 
The direct impact of the brains microenvironment including the influence of astrocytes, 
pericytes, microglia and perivascular cells on the induction and maintenance of the blood-
brain barrier and its specific phenotype have been studied intensively, and their contribution 
seems critical (Abbott, 2002; H. C. Bauer and H. Bauer, 2000; Janzer and Raff, 1987, Chow 
and Gu, 2015). The signaling pathways and involved mediators are not yet completely 
identified. In contrast to epithelial cells, which develop barrier properties spontaneous in cell 
culture, endothelial cells require a specific microenvironment. Even if the physical barrier 
itself is generated by overlapping endothelial cells the interaction with adjacent cell layers is 
required. The underlying basal membrane contributes a fundamental role in the 
establishment of the BBB function. It connects pericytes, perivascular cells, microglia and 
astrocytes with the endothelial network that forms the selective and brain-specific barrier 
system (Figure 3). Additionally to the local parenchymal brain microenvironment is the 
leptomeningeal cell sheet, which follows the penetrating vessels. Its contribution to BBB 
induction has not yet been proven, but the close relationship makes a consideration possible 
(ALCOLADO et al., 1988; Hutchings and Weller, 1986).  
 
1.4.1  Astrocytes  
	
The structural characteristic features are their specialized end-feet that ensheaths almost the 
entire surface of CNS vessels (Persidsky et al., 2006, Engelhardt and Liebner, 2014) 
typically containing the glial fibrillary acidic protein. They participate in neuron care, regulate 
extra cellular electrolyte concentration, clear and recycle neurotransmitter, maneuver 
immune reactions and regulate BBB function (Gee et al., 2005). Astrocyte development 
starts in late gestations stages and is therefore possibly not involved in BBB inducing events 
(Liebner et al., 2018). However their contribution to BBB maintenance is widely accepted. 
Mainly due to the close anatomical location to the endothelium (Figure 3) and release of 
soluble factors like transforming growth factor-β (TGF-β), glialderived neurotrophic factor 
(GDNF), basic fibroblast growth factor (bFGF) and angiopoietin 1 (ANG-1), establishing a 
crosstalk to the underlying endothelium by binding to the the endothelium-specific receptor 
TIE2 (Lai and Kuo, 2005, Sobue et al. 1999, Lee et al., 2003). In-vitro experiments have also 
demonstrated an improved barrier function in astrocyte co-cultures compared to endothelial 
monocultures (Y. Hayashi et al., 1997). Forced by increased TJ formation and reduced gap 
junctional area, reducing BBB permeability (Tao-Cheng and Brightman, 1988). In addition 
astrocyte differentiation is induced by the endothelial-derived factor LIF to point out this 
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important network differentiation (Mi et al., 2001). Moreover, astrocytes are involved in 
electrolyte homeostasis necessary for proper neuronal function, as neuronal activity would 
lead to an increase of potassium (K) concentration. The K+- Ions are buffered by uptake into 
the astrocytic endfeet, and later released over juxtavascular processes by a specific 
transport system the Kir4.1 K+ channel. (Price et al. 2002). Further, this process drives an 
osmotic water uptake a mechanism that needs regulation to prevent intense cellular swelling. 
Therefore the water gets redistributed under aquaporin 4 (AQP4) water channel control 
located also on the astrocytic endfeet (Abbott et al. 2006, Zlokovic et al., 2008). Astrocyte 
involvement in maintaining BBB integrity has been shown by signaling via the glycoprotein 
Sonic hedgehog (SHH). Here, the needed receptors were found on endothelial cells 
contributing to this pathway fundamental to BBB function and even limiting immune cell 
access to the CNS by downregulation of proinflammatory molecules (Alvarez et al. 2011). In 
fact, astrocytes further participate also in vascular control by smooth muscle cell signaling 
and blood flow regulation and even be involved in the development of neurodegenerative 
diseases caused by alterations of interactions with the endothelium.  
 
1.4.2  Pericytes  
	
Pericytes stay in close contact to the abluminal surface of cerebral vessels and therefore in 
direct contact with capillary endothelium (Allt and Lawrenson, 2001) (Figure 3). The specific 
role of pericytes for the BBB is represented by its highest degree of vessels coverage 
compared to other peripheral organs (Armulik et al., 2011). Pericytes are capable of multiple 
tasks including vessel wall stability, blood flow regulation by dynamic diameter changes and 
maintaining BBB integrity (Winkler et al., 2011). Animal models suggest an important role in 
early vascular formation and BBB establishment, as pericytes deficient mice result in 
embryonic lethality. Pericyte involvement is also shown in TJ formation and reduction of 
leucocyte adhesion molecule reduction during BBB development (Lindahl et al., 1997). The 
limited information and ongoing investigation on pericyte involvement is due to several 
factors including difficulty in labeling and extracting pericytes for in vitro analyses as their 
surface markers vary depending on tissue and function. However, in most cases pericytes 
express the platelet- derived growth factor (PDGF) receptor β, commonly used for detection 
(Barreiro et al., 2002). Improvement in pericyte identification is likely to lead to increased 




Figure 3: Representing the close anatomical relationship between endothelium, basement membrane, pericytes 
and astrocyte end feeds, all involved in BBB formation and maintenance (adapted from Chow and Gu, 2015).  
1.5  Blood brain barrier function  
1.5.1  Physiologic conditions 
 
The brain comprises only about 2% of body weight, yet it receives up to 20% of total cardiac 
output, making it one of the most intensely perfused organs of the body. Because of the 
importance to maintain a constant intracranial pressure (ICP) within normal ranges and also 
to provide an appropriate ionic milieu for neuronal function, water and solute transport from 
the blood into the brain parenchyma is controlled by the BBB (Abbott, 2005; Bechmann et al., 
2007; Obermeier et al., 2013). A selection of molecular transport systems and enzymes 
exists to control the transportation across the BBB. Most of them are members of the solute 
carrier family capable of transporting water-soluble molecules like glucose and amino acids 
into the central nervous system (Ohtsuki and Terasaki, 2007). The regulation and restrictions 
of fluids and ions between blood and brain are necessary to produce the brain-specific 
interstitial fluid (ISF), indispensable for an optimal neuronal function (Hladky and Barrand, 
2016). The ISF is similar in its composition to blood plasma but has a much lower protein 
content. The ionic concentrations of K+ and Ca2+ are also significantly lower. The BBB 
protects and ensures fluctuations of the ISF ion concentration making it independently 
regulated from the blood level concentrations (Cserr and Bundgaard, 1984).But not only the 
intake of molecules is regulated by the BBB, but it also prohibits the efflux of 
neurotransmitters and neuroactive agents. This way centrally released transmitters do not 
influence peripheral signaling and crosstalk can be blocked.  
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1.5.2   Pathologic conditions 
	
Disturbance of BBB function has been described following a variety of CNS pathologies 
(Daneman, 2012). The onset of disruption ranges widely from traumatic injuries, over 
inflammatory response, to ischematic incidences. Resulting in molecular changes, immune 
cell infiltration and can end in a complete breakdown of local or global BBB homeostasis. 
While this breakdown can improve immune cell infiltration, and enhance injury repair 
processes, extended BBB dysfunction may result in life-threatening edema and increased 
intracranial pressure (Nag et al., 2009). In general, BBB breakdown is a secondary 
phenomenon based of a traumatic brain injury or perfusion error, like stroke. Yet it is unclear 
if BBB dysfunction may play a factor in the onset of certain CNS pathologies like multiples 
sclerosis (MS), Alzheimer’s disease (AD), or epilepsy (Zlokovic, 2008, Correale and Villa, 
2007, van Vliet et al., 2007, Oby and Janigro, 2006). Multiple mechanisms are involved in 
BBB dysfunction including, TJ disruption, increased transcellular transport and leucocyte 
recruitment. A variety of molecules and signals are involved in such mechanisms like VEGF 
(vascular endothelial growth factor), inflammatory cytokines (IL-1.IL-6,TNF-alpha) and MMPs 
(matrix-metalloproteinases) have been found (Clark et al., 1997). Hence, exalted MMP-2 and 
MMP-9 can be measured in peripheral blood of patients suffering a stroke. The elevated 
levels correlate with objective stroke scores and infract size on image quantifications 
(Montaner et al., 2001). MMPs as zinc-depended proteases seem to be involved by cleaving 
TJ proteins and therefore promote TJ discontinuity. An adverse effect, that can be reversed 
with MMP inhibitors shown in ischematic animal models (A. T. Bauer et al., 2010; Romanic et 
al., 1998). Further, VEGF is not only an angiogenic factor during developmental 
angiogenesis, but also contributes to vessel permeability (T. Hayashi et al., 1997) (Z. G. 
Zhang et al., 2000). In fact elevated blood levels can be detected in patients following stroke 
and interestingly in MS patients suffering a relapse compared to remission (Su et al., 2006). 
In-vitro studies demonstrated that VEGF addition reduces transendothelial electric residence 
measurements along with down regulation of claudin-5 and occludin as part of the BBB TJ 
demonstrating the involvement in BBB dysfunction (Argaw et al., 2009). Permeability can 
additionally be regulated by the presence of inflammatory cytokines. Here TNF-alpha and IL-
1 promote BBB leakage by internalization of TJ proteins in ischematic pathologies (Kim et al., 
1992, Patel et al., 2003, Sozen et al., 2009). In contrast, IL-25 has shown to protect and 
reestablish BBB function and continuity (Sonobe et al., 2009). Although several mediators 
involved in BBB maintenance and dysfunction have been described in detail, understanding 
their interplay in the context of CNS pathologies will hopefully allow the development of 
additional treatment strategies aiming at the protection of secondary brain damage due to 
BBB disruption.  
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2.  Open questions and scientific approach 
 
Since most of the literature investigating the BBB under physiological and pathological 
conditions is only focused on the capillary segment or rather ill-defined microvessels, there is 
an apparent need for a systematic approach to investigate BBB-typical characteristics of the 
endothelial layer along the vascular tree of CNS vessels.  
 
Therefore, the present thesis addressed the following questions. 
1. How does the ultrastructural composition of endothelial cell contacts differ along the 
vascular tree of the blood-brain barrier? 
 
2. Are there detectable differences in the molecular composition between the TJ 
complexes in arteries, capillaries and veins? 
 
3.  In which way does the direct contact of endothelial cells to adjacent astrocytes affect 
the ultrastructure or the distribution of critical TJ proteins in parenchymal and 
meningeal vessels?  
 
 
Therefore we analyzed a total of over 1000 vessels using a systematic approach in a 
standardized mouse model comparing the arterial, capillary and venous segments of 
parenchymal and leptomeningeal vessels in regard to their ultrastructure and the molecular 
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Abstract The identification of the ‘‘paucity of transporta-
tion vesicles’’ and ‘‘belt-like’’ tight junctions (TJs) of
endothelial cells as the ‘‘morphological correlate of a
blood–brain barrier’’ (BBB) by Reese and Karnovsky (J
Cell Biol 34:207–217, 1967) has become textbook
knowledge, and countless studies have helped to further
define the elements, functions, and dynamics of the BBB.
Most work, however, has focused on parenchymal capil-
laries or less clearly defined ‘‘microvessels’’, while a sys-
tematic study on similarities and differences between BBB
architecture along the vascular tree within the brain and the
meninges has been lacking. Since astrocytes induce
endothelial cells to display BBB-typical characteristics by
sonic hedgehog and Wnt/b-catenin signaling, we hypoth-
esized that BBB-typical features should be most pro-
nounced in parenchymal capillaries, where endothelium
and astrocytes are separated by a basement membrane only.
In contrast, this intimate contact is absent in lep-
tomeningeal vessels, thereby potentially affecting BBB
architecture. However, here, we show that claudin-3,
claudin-5, zonula occludens-1, and occludin as typical
constitutes of BBB TJs are comparably distributed in all
segments of the parenchymal and the meningeal vascular
tree of C57Bl6 mice. While electron microscopy revealed
equally occluded interendothelial clefts, arterial vessels of
the brain parenchyma but not within the meninges exhib-
ited significantly longer TJ overlaps compared to capillar-
ies. The highest density of endothelial vesicles was found
in arterial vessels. Thus, endothelial expression of BBB-
typical TJ proteins is not reflected by the distance to sur-
rounding astrocytes, but electron microscopy reveals sig-
nificant differences of endothelial specification along
different segments of the CNS vasculature.
Keywords Blood–brain barrier ! Tight junctions !
Endothelial cells ! Neurovascular unit
Introduction
The concept of a blood–brain barrier (BBB) started with
Paul Ehrlich’s experiments using intravenously applied
hydrophilic dyes which change their color depending on
their oxidative state, and thus was injected to judge the
oxygen consumption of different organs. A prerequisite of
such judgment, however, would have been equal distribu-
tion at the beginning of the experiment, which as Ehrlich
noted, was not the case as the brain, parotis, and testes
remained ‘‘white as snow’’ (Ehrlich 1885). Comparing the
lethal doses of toxins injected intravenously versus
intrathecally, his student Lewandowski correctly concluded
that brain capillaries constitute a unique barrier, which is
capable of holding back certain molecules from entering
the CNS (Lewandowski 1900). The term BBB, however,
was coined later by the French-German Physiologist Lina
Stern who summarized her and others findings in an article
S. Hanske and F. Dyrna contributed equally.
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about ‘‘la barriere hematoencephalique’’ (Stern and Gautier
1921) with a yet undefined architecture. It was 46 years
later that Reese and Karnovsky (1967) identified the typical
belt-like tight junctions (TJs) as ‘‘morphological correlate
of a BBB’’ and a ‘‘paucity of transportation vesicles’’ as a
more dynamic feature of limited entrance to the brain’s
parenchyma.
In 1987, Janzer and Raff have shown that astrocytes are
capable of inducing BBB properties in endothelial cells
(Janzer and Raff 1987) and similar findings were reported
by several authors (Neuhaus et al. 1991; Hayashi et al.
1997). Mechanistically, astrocyte-secreted sonic hedgehog
binds to endothelial Patched-1 causing release of
Smoothened which causes junctional protein expression
and downregulation of cytokines and ICAM-1 expression
through activation of the transcription factor Gli-1 (Alvarez
et al. 2011). Wnt/beta-catenin signaling also plays a crucial
role in angiogenesis and BBB formation as indicated by
upregulation of the typical BBB markers claudin-3 and
Glut-1 (Liebner et al. 2008; Daneman et al. 2009). In fact,
pericytes are also shown to be involved in the establish-
ment of typical BBB properties (Gerhardt and Betsholtz
2003; Thanabalasundaram et al. 2010; Daneman et al.
2010; Ramsauer et al. 2002; Hatherell et al. 2011).
Importantly, pericyte-deficient mice lacking PDGFR-b
signaling did not show altered expression patterns for tight
junction proteins, but an upregulation of factors leading to
increased vascular permeability, such as angiopoietin-2,
plasmalemmal vesicle-associated protein-1, and leukocyte
adhesion molecules, instead (Daneman et al. 2010).
However, despite the increasing data on BBB formation,
maintenance and the general expression of a diversity of
critical TJ proteins, such as claudin-5, claudin-3, zonula
occludens-1 (ZO-1), and occludin (Engelhardt and Sorokin
2009; Pfeiffer et al. 2011), in brain parenchymal as well as
meningeal vessels (Pfeiffer et al. 2011), it is often
neglected that the architecture of the vascular tree signifi-
cantly differs from arteries over capillaries to veins. Only
in capillaries, the astrocytic endfeet forming the glia limi-
tans is in close relationship to the endothelial cells, being
separated by a basement membrane, only. In all other
segments, the perivascular spaces (PVS), smooth muscle
cells, and pericytes can be interposed between the glia
limitans and the endothelial layer (Dyrna et al. 2013).
Nevertheless, studies addressing BBB function predomi-
nantly only focus on the capillary segment or less clearly
defined ‘‘microvessels’’, while data on BBB TJs in larger
vessels or vessels outside the neuropil are rare (Ge et al.
2005). Thereby the critical influence of adjacent popula-
tions, such as smooth muscle cells of the tunica media,
perivascular macrophages, or extracellular components of
the ensheathing basement membranes, is often neglected.
This issue is, therefore, appreciated by the term
‘‘neurovascular unit’’ (NVU), which emphasizes the inter-
dependencies of the neural and the vascular populations
(Zlokovic 2008; del Zoppo 2010). Moreover, the different
segments of the cerebrovasculature display different func-
tional properties, as the post-capillary venules, but not
capillaries represent preferential sites of leukocyte
extravasation under inflammatory conditions and, there-
fore, allow cells to enter the neuropil or PVS (Engelhardt
and Wolburg 2004; Owens et al. 2008).
In the present study, we systematically examined and
compared characteristics of the endothelial layer in capil-
lary, arterial, and venous vessels of various regions of the
brain parenchyma (cortex, hippocampus, cerebellum, and
striatum) as well as the meninges, where a direct contact to
astrocytes is not established. Therefore, we applied high-
quality electron microscopy and further analyzed the
composition of BBB-typical TJ-associated proteins along
the vascular tree by fluorescence microscopy.
Materials and methods
Setup
The animals used for our experiments were kept according
to the European Communities Council Directive (86/609/
EEC) in a temperature (21–22 "C) and humidity (45–60 %)
controlled room with 12 h of light/dark cycle with free
access to food and water at any time. C57Bl6/J mice were
sacrificed followed by transcardial perfusion with either
50–100 ml of freshly prepared saline (Merck, Darmstadt,
Germany) solution (n = 12) for immunohistological anal-
yses, or with 50–100 ml phosphate-buffered saline (PBS,
devoid of Mg2? and Ca2?, Merck) and 200 ml of a phos-
phate-buffered fixative containing 4 % paraformaldehyde
(Serva, Heidelberg, Germany) and 2 % glutaraldehyde
(Serva) for ultrastructural analyses (n = 6). After perfu-
sion, brains were carefully removed from the skull with the
meninges being preserved. To further study meningeal
vessels, we used p3 mice (n = 6) to perform the whole
head sections to maintain the meninges in situ and fully
intact.
Electron microscopy
For electron microscopy, serial sections cut by a vibratome
(Leica Microsystems, Wetzlar, Germany) with a thickness
of 50 lm were collected in cooled PBS. The sections were
stained with 0.5 % osmium tetroxide (EMS, Hatfield, PA,
USA) in PBS (Merck) for 30 min and subsequently rinsed
in PBS followed by dehydration with 30, 50, and 70 % of
ethanol (J.T. Baker, Deventer, Netherlands). Afterwards,




70 % ethanol for 1 h, before the tissue was further dehy-
drated using 80, 90, 96, and 100 % ethanol and finally
propylene oxide (Sigma Aldrich, Steinheim, Germany).
The sections were incubated in Durcupan (Sigma Aldrich)
and embedded in between coated microscope slides and
cover slips before the polymerization process at 56 "C for
48 h. Regions of interests were located by light micro-
scopy, marked, and transferred on blocks of resin for a
second polymerization step. Finally, the embedded tissue
was cut into semi-thin sections, and areas for ultrastructural
analysis were trimmed before ultra-thin sections of 55 nm
in thickness were acquired using an ultra-microtome (Leica
Microsystems) and transferred on formvar-coated grids.
Furthermore, sections were stained with lead citrate for
6 min.
The analysis was performed using a Zeiss EM900
transmission electron microscope and a Zeiss SIGMA
electron microscope (both, Zeiss NTS, Oberkochen,
Germany).
Immunofluorescence
For immunofluorescence-based analyses, the PBS-perfused
brains were removed from the skull and immediately snap-
frozen in cryo embedding medium (Sakura Finetek, Tor-
rance, USA) using isopentane (Sigma Aldrich) on dry ice
to minimize freezing related artifacts and to circumvent
paraformaldehyde containing fixatives. Next, cryostat sec-
tions of 16 lm thickness were cut using a Leica cryostat
(Leica Microsystems). The sections were fixed using
100 % ethanol for 5 min prior to immunofluorescence
labeling, except for claudin-12, which required post-fixa-
tion via 4 % paraformaldehyde (Sigma Aldrich) in PBS.
After fixation, samples were rinsed with PBS prior to the
blocking step with 0.5 % Triton X100 (Roth, Karlsruhe,
Germany) and 5 % of normal goat serum (NGS, Sigma
Aldrich) in 0.1 M PBS for 45 min at room temperature to
prevent unspecific binding of the applied antibodies.
Afterwards, the samples were incubated with primary
antibodies mouse/guinea pig anti-occludin (Antibodies-
online, Aachen, Germany/Acris antibodies, Herford, Ger-
many; 1:200), rabbit anticlaudin-5 (Abcam, Cambridge,
UK; 1:200), rabbit anti claudin-3 (Abcam, 1:200), rabbit
anti- ZO-1 (Abcam, 1:200), or rabbit anti claudin-12 (IBL,
Minneapolis, USA; 1:20). For detection of vascular smooth
muscle cells, mouse anti-alpha smooth muscle actin (a-
SMA) (Abcam, 1:200) was applied, while endothelial cells
were identified using Alexa Fluor 647-conjugated Griffonia
simplicifolia agglutinin isolectin B4 (IB4) (Invitrogen,
Carlsbad, CA, USA, 1:100). Afterwards, samples were
rinsed in PBS for 30 min and treated with appropriate
highly fluorochromated secondary antibodies (Invitrogen)
for 90 min in a 1:250 dilution in PBS containing 0.5 %
NGS and 0.03 % Triton. Finally, samples were rinsed with
PBS and, where applicable, stained for nuclei using 40,6-
diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma
Aldrich, 1:10,000) for 5 min, followed by additional rins-
ing and sealing in a fluorescence mounting medium (Dako,
Hamburg, Germany). The sections were analyzed with an
Olympus BX51 fluorescence microscope, and images were
captured using an XM10 digital camera (both, Olympus,
Hamburg, Germany).
Statistical analysis
The relative occludin/claudin-5 immunoreactive TJ strand
length was assessed by measuring the length immunopos-
itive for occludin and claudin-5 for individual TJ strands in
arteries, capillaries, and veins of the brain parenchyma in
different animals using the Image J software 1.48v (NIH,
USA). In total, analyses thus included 800–1000 lm of TJ
strands for each vessel type per mouse (n = 5).
Ultrastructural images and lengths of TJ overlaps were
acquired with the ATLAS software (Zeiss NTS, Oberko-
chen, Germany). To analyze the density of endothelial
vesicles, cytoplasmic vesicles were counted on three dif-
ferent areas per vessel, each measuring 5 lm. Afterwards,
the average vesicle density per micrometer of vascular
circumference was calculated and compared for arteries,
veins, and capillaries of the parenchyma and the meninges.
In total, the analyses included over 1000 vessels in six mice
for tight junction measurements and over 450 vessels for
the calculation of vesicle densities.
Statistical analysis was performed with Graph Pad Prism
5.01v (GraphPad Software Inc., La Jolla, CA, USA) using
the Kruskal–Wallis test as a non-parametric test, followed
by Dunn’s multiple comparison test to compare in between
groups.
Results
Differences in TJ composition and architecture can
be identified by multiple fluorescence labeling
and electron microscopy
To compare the composition and the morphology of
parenchymal and meningeal TJs in different segments of the
vascular tree, we first applied multiple fluorescence labeling
for typical TJ proteins on CNS tissue and tissue of periph-
eral organs to assure the possibility to identify different
expression patterns of the respective antigens. Therefore,
the expression of occludin, claudin-3, claudin-5, and ZO-1
was compared on meningeal, parenchymal, heart, and liver
tissue. Furthermore, the endothelial marker IB4 was used to




tree. In peripheral organs, the vasculature regularly dis-
played characteristic differences in the expression of the
respective TJ proteins. While vessels of the heart are
characterized by a solitary lack of occludin, vessels of the
liver also showed an almost lacking immunoreactivity for
occludin, claudin-3, and ZO-1, which is in line with pre-
vious findings reporting an almost lacking immunoreac-
tivity for TJ- associated antigens in the vasculature of the
liver, whereas a strong immunoreactivity was observed in
bile ducts and TJs between adjacent hepatocytes (Rahner
et al. 2001). In contrast, occludin, claudin-3, claudin-5, and
ZO-1 appeared to be equally distributed in vessels from
parenchymal and meningeal tissue (Fig. 1a).
Furthermore, we confirmed that differences in TJ
architecture can be displayed by transmission electron
microscopy. Of note, parenchymal and meningeal vessels
are characterized by TJs, which completely seal the inter-
cellular cleft. In contrast, vessels of heart and liver tissue
regularly showed detectable interendothelial clefts
(Fig. 1b). Therefore, differences in the TJ architecture can
be displayed by multiple fluorescence labeling and high-
quality electron microscopy.
Typical TJ proteins are equally distributed
along the vascular tree of parenchymal
and meningeal vessels
To investigate whether differences of the vascular archi-
tecture (Dyrna et al. 2013) provoke a differential expres-
sion of typical TJ constituents along the vascular tree, we
applied double fluorescence labeling for occludin, claudin-
3, claudin-5, and ZO-1 in combination with a-SMA and
DAPI to differentiate between arterial, capillary, and
venous vessels. Therefore, vessels were categorized as
described before (Hawkes et al. 2011). Vessels with a
diameter of less than 10 lm were regarded as capillaries,
while vessels with a diameter exceeding 10 lm and posi-
tive immunoreactivity for a-SMA were regarded as arterial
vessels, whereas vessels of a larger diameter than 10 lm
and negative a-SMA immunoreactivity were regarded as
veins (Hawkes et al. 2011).
Importantly, the analysis of the expression patterns
revealed that none of the applied TJ markers exhibited a
differential distribution along the vascular tree of
parenchymal vessels, which is exemplarily shown for
claudin-5 (Fig. 2a).
Moreover, the mentioned TJ proteins were equally
detected in arteries, capillaries, and veins of meningeal
vessels, which are lacking direct contacts to astrocytes
(Fig. 2b). Of note, we neither observed differences in the
distribution of the applied TJ markers between different
vascular segments, nor between meningeal or parenchymal
vessels. Thus, the presence or absence of the astrocytic
contact does not affect a differential expression for occlu-
din, claudin-5, claudin-3, and ZO-1 along the different
segments of the vascular tree of CNS vessels.
After demonstration of a comparable distribution of
critical TJ proteins, we exemplarily analyzed the length of
individual TJ strands immunoreactive for occludin and
claudin-5 for arteries, capillaries, and veins of the brain
parenchyma to calculate the ratio of occludin/claudin-5
immunoreactive TJ strand length using triple immunoflu-
orescence labeling. As both proteins exhibited an almost
complete co-localization, comparison of the relative
occludin/claudin-5 strand length within arteries, capillaries,
and veins impressively failed to reach statistical signifi-
cance (Supplementary Fig. 1A). In general, claudin-12,
which is also expressed in the cerebral vasculature (Nitta
et al. 2003), was also found in parenchymal and meningeal
arteries, capillaries, and veins, but appeared to be only
weak (Supplementary Fig. 1B). However, as the respective
antibody (IBL) strictly required paraform-mediated fixation
of the tissue, which prohibits detection of the other TJ
markers applied, direct comparison was not possible. Other
commercially available antibodies for claudin-12 often
failed to provide specific labeling.
Ultrastructural analysis did not reveal apparent
differences of TJ tightness along the vasculature
of the meninges and the parenchyma
To rule out differences of TJ architecture, which cannot be
correlated to expression patterns of respective proteins, we
further compared capillary, arterial, and venous TJs of the
parenchyma and the meninges for the presence of structural
differences at an ultrastructural level. Importantly,
although the direct contact of astrocytic endfeet to the
endothelial layer is clearly inhibited by additional cell
layers of the tunica media and, if present, PVS in non-
capillary vessels of the brain parenchyma proper,
endothelial overlaps were always found to be occluded,
irrespective of their position in the vascular tree (Fig. 3a).
cFig. 1 a Fluorescence microscopy images illustrating that the
combination of markers for occludin, claudin-3, claudin-5, and ZO-
1 allows identification of differential TJ composition when comparing
vessels of CNS tissue with peripheral vessels of heart and liver. While
the vasculature of the heart is characterized by a lack of occludin
only, vessels of the liver exhibited an almost lacking immunoreac-
tivity of the vascular endothelium for occludin, claudin-3 and ZO-1.
In contrast, the endothelium of CNS tissue was found to express all of
the applied TJ markers. IB4 was used to demark the endothelial cells.
Arrows IB4-positive vessels in the liver, bd bile duct. b Electron
microscopy revealed occluded interendothelial spaces between adja-
cent endothelial cells of the brain parenchyma, while detectable clefts
were regularly observed in vessels from heart and liver. e endothe-










Furthermore, we systematically analyzed arteries, capil-
laries, and veins of the meninges, all of which are com-
pletely surrounded by the subarachnoid space and
additional layers of leptomeningeal mesothelial cells.
Again, TJs of meningeal vessels were found to completely
seal the interendothelial cleft with no apparent differences
between arteries, capillaries, and veins (Fig. 3b).
Comparison of the length of TJ overlaps
demonstrated significant differences
along the vascular tree of parenchymal vessels
As electron microscopy did not reveal differences in the
general morphology of TJs along the vascular tree of
parenchymal and meningeal vessels, we further analyzed
the length of TJ overlaps in arterial, capillary, and venous
blood vessels of the brain parenchyma proper and the
meninges. Moreover, given the fact that the architecture of
the neurovascular unit was found to differ between vessels
of different brain regions (Zhang et al. 1990; Pollock et al.
1997), we systematically compared the lengths of TJ
overlaps of cortical, striatal, hippocampal, and cerebellar
vessels. To rule out artifacts by tangential sectioning, the
analyses were focused on cross sections, only.
Here, comparison of arterial, capillary, and venous
vessels revealed significant differences with consistently
shorter TJ overlaps in capillaries compared to arteries of
the cortex (p\ 0.05), the striatum (p\ 0.05), the cere-
bellum (p\ 0.05), and the hippocampus (p\ 0.01).
However, the comparison of the length of TJ overlaps in
meningeal vessels did not reveal significant differences
(Kruskal–Wallis test, Dunn’s Multiple comparison, n = 6)
(Fig. 4a).
Furthermore, we addressed the differential influence of
endothelial contacts to astrocytes, vascular smooth muscle
cells, or to PVS spaces on the length of TJ overlap.
However, the differences failed to reach statistical signifi-
cance (p = 0.2), although we also observed that a trend to
longer TJ overlaps in endothelial cells directly contacting
vascular smooth muscle cells (Fig. 4b). Interestingly, even
after extensive search for parenchymal vessels being sur-
rounded by true PVS, we were only able to identify four
vessels surrounded by true PVS among 720 parenchymal
vessels being analyzed (Supplementary Fig. 2).
Arterial vessels regularly exhibit higher densities
of endothelial vesicles throughout the brain
and the meninges
As Reese and Karnovsky already proposed that BBB
characteristics of CNS vessels may also result from the
relative paucity of transendothelial vesicle trafficking
compared to peripheral vessels, we further compared the
density of endothelial vesicles in arteries, capillaries, and
veins of different regions of the brain parenchyma and the
meninges. For this purpose, the number of endothelial
vesicles was counted in a distance of 5 lm of vascular
circumference to calculate the density of vesicles per
micrometer of vascular circumference (Fig. 5a). Here,
direct comparison of arteries, veins, and capillaries of
cortex, hippocampus, striatum, and the meninges revealed
significantly higher vesicle densities in arteries compared
to capillaries (cortex, p\ 0.05; hippocampus, striatum, and
meninges, p\ 0.01) (Fig. 5b). While significant differ-
ences between veins and capillaries were never observed,
the vesicle density of arteries appeared to be significantly
higher than in veins of the cortex and the meninges
(p\ 0.05). Furthermore, a trend to higher arterial vesicle
amounts was observed compared to veins in hippocampus,
striatum, and cerebellum (Kruskal–Wallis test, Dunn’s
multiple comparison, n = 6) (Fig. 5b). Therefore, the
highest amounts of endothelial vesicles per micrometer of
vascular circumference were invariably found in arteries in
each of the analyzed regions of the brain as well as the
meninges.
Discussion
The specialized endothelium of CNS vessels with pro-
nounced intercellular belts of TJs prohibiting paracellular
permeability is usually regarded as the functional core of
the BBB (Reese and Karnovsky 1967; Wolburg and Lip-
poldt 2002; Bechmann et al. 2007; Obermeier et al. 2013).
As a consequence, loss of BBB function under pathological
conditions (e.g., stroke, ischemia/reperfusion) is often pri-
marily attributed to dysfunctional or disrupted TJ com-
plexes (Fischer et al. 2000; Wolburg et al. 2003; Sandoval
and Witt 2008; Jiao et al. 2011; Liu et al. 2012). However,
a proper BBB function is maintained by various signaling
cascades and cellular populations of the NVU (Zlokovic
2008; Daneman et al. 2010; Alvarez et al. 2011) and is
further influenced by peripheral factors as recently shown
for the microbiota of the gut (Braniste et al. 2014). The
present study was, therefore, aimed to investigate whether
differences of function and cellular architecture of the
NVU along the different segments of the CNS vasculature
induce distinct patterns of endothelial specialization under
bFig. 2 Expression pattern of typical TJ proteins, such as occludin,
claudin-3, claudin-5, and ZO-1, is consistent along the parenchymal
(a) and meningeal (b) vasculature, irrespective of the segment of the
vascular tree and the diameter of the respective vessels (exemplarily
shown for claudin-5). Capillaries, veins, and arteries were differen-
tiated by diameter and immunoreactivity for a-SMA. Of note, the
presence of smooth muscle cells as demarked with a-SMA physically








physiological conditions. For this purpose, the composition
of endothelial TJs in arterial, capillary, and venous seg-
ments was analyzed by classical markers using fluores-
cence microscopy. Furthermore, the ultrastructural aspects
of the endothelial layer were systematically studied in
different segments of the vascular tree of meningeal and
parenchymal vessels.
Assuring that differences in the architecture of
endothelial TJs can be detected by fluorescence micro-
scopy, multiple fluorescence labeling of occludin, claudin-
3, claudin-5, and ZO-1 was applied on tissue from the CNS
and peripheral organs. Thus, characteristic differences in
the expression of TJ proteins were detected when com-
paring tissue obtained from CNS, heart, and liver (Fig. 1a),
which was a prerequisite of further analyses. Moreover, as
BBB-typical TJs are often characterized using freeze
fracture analyses by scanning electron microscopy (Stae-
helin 1973; Nagy et al. 1984), we initially confirmed that
transmission electron microscopy and the applied tissue
preparation allow visualization of differences of TJ tight-
ness by ultrastructural comparison of peripheral and CNS
vessels (Fig. 1b).
As there are numerous data reporting on endothelial
heterogeneity (Chi et al. 2003; Ge et al. 2005) or differ-
ential expression of TJ-associated proteins for the
endothelium of the choroid plexus, parenchymal and
meningeal vessels as well as ependymal cells in general
(Pfeiffer et al. 2011), we systematically analyzed whether
the critical TJ proteins, such as occludin, claudin-3, clau-
din-5, and ZO-1, are equally distributed throughout arterial,
capillary, and venous vessels of the brain parenchyma and
the meninges. Here, the applied TJ markers neither
appeared to be preferentially distributed in arteries, capil-
laries, or veins nor in parenchymal or meningeal vessels, as
exemplarily shown for claudin-5 (Fig. 2a). Thus, critical TJ
proteins appear to be equally distributed throughout CNS
vessels, irrespective of their position in the vascular tree
and also irrespective of differential influences from
neighboring populations, such as smooth muscle cells in
bFig. 3 Ultrastructural analyses revealed presence of BBB-typical TJs
in each segment of the vascular tree with no apparent differences
between parenchymal (a) or meningeal (b) vessels. Interendothelial
clefts were invariably found to be occluded, irrespective of the
diameter of the vessels being analyzed or the position in the vascular
tree. e endothelium, asterisk basal lamina, SMC smooth muscle cell
Fig. 4 a Analysis of the lengths
of TJ overlaps revealed
significantly longer overlaps in
arteries compared to capillaries
throughout the brain, while
differences in the meninges
failed to reach statistical
significance. b Grouping the
vessels for endothelial cells
either showing direct contacts to
astrocytic endfeet (capillaries
and smaller veins), to smooth
muscle cells (arteries) or to
surrounding perivascular spaces
to address a potential impact of
neighboring structures on
endothelial TJ formation did not
result in statistically significant
differences. However, a trend to
longer TJ overlaps between
endothelial cells surrounded by
smooth muscle cells was
regularly observed. *p\ 0.05;
**p\ 0.01; Kruskal–Wallis
test; Dunn’s multiple
comparison; n = 6; bars are





arterial vessels and astrocytic contacts in the capillary
segment (Bechmann et al. 2007; Zlokovic 2008; Dyrna
et al. 2013). Since recruitment of leukocytes under patho-
logical conditions is shown to take place in post-capillary
venules (Engelhardt and Wolburg 2004; Owens et al.
2008), but not within the capillary segment, thereby
strongly depending on the composition of extracellular
components of vascular basement membranes (Sixt et al.
2001), it is a remarkable feature that these functional dif-
ferences of the vasculature are not reflected by the
molecular composition of TJ strands. On the other hand,
these findings may further underline the assumption that
leukocyte recruitment across the endothelial layer occurs
independently of opening TJ complexes (Wolburg et al.
2005). In addition, differential expression of TJ proteins
was found to reduce BBB permeability for small soluble
molecules in a model of autoimmune encephalomyelitis,
while leukocyte recruitment across the endothelial layer
remained unaffected (Pfeiffer et al. 2011). Furthermore, the
expression as well as an equal distribution for occludin,
claudin-3, claudin-5, and ZO-1 was invariably observed in
meningeal vessels, which by definition are lacking a direct
contact of astrocytic endfeet to endothelial cells as vessels
of the meninges are surrounded by subarachnoid space and
additional layers of leptomeningeal mesothelial cells
(Fig. 2b). Interestingly, the influence of a direct contact to
astrocytes was initially believed to induce BBB-typical TJ
strands (Janzer and Raff 1987), although this capability
was later also shown for pericytes (Hori et al. 2004;
Daneman et al. 2010; Armulik et al. 2010). Furthermore,
the influence of secreted factors, such as glial cell line-
derived neurotrophic growth factor, interleukin-6,
Fig. 5 a Vesicles were counted in a distance of 5 lm of vascular
circumference to calculate the density of endothelial vesicles per
micrometer of arterial, venous and capillary vessels. b Significantly,
higher amounts of endothelial vesicles were regularly found in
arteries as compared with capillaries of cortex, hippocampus,
striatum, and the meninges, while the differences between cerebellar
vessels failed to reach statistical significance. In cortical and
meningeal arteries, the vesicle density was also significantly higher
than in the respective veins, while a trend for higher vesicle densities
was also demonstrated for cerebellum, hippocampus, and striatum. Of
note, the highest density of endothelial vesicles was found in
meningeal arteries. *p\ 0.05; **p\ 0.01; ***p\ 0.001; Kruskal–
Wallis test; Dunn’s multiple comparison; n = 6; bars are given as




fibroblast-growth factor 2, and sonic hedgehog, should be
considered (Arthur et al. 1987; Sun et al. 1997; Igarashi
et al. 1999; Sobue et al. 1999; Alvarez et al. 2011), all of
which have shown to enhance BBB properties in
endothelial cells and could access endothelial cells via the
cerebrospinal or interstitial fluid irrespective of their posi-
tion in the vascular tree. Although the present study
revealed that the expression of occludin, claudin-3, clau-
din-5, and ZO-1 is indeed invariable along the vascular tree
under physiological conditions, functionally relevant
modifications of the respective proteins, which cannot be
detected by immunofluorescence microscopy are conceiv-
able (Bauer et al. 2014). In particular, occludin as well as
claudins are targeted by several kinases, which can phos-
phorylate the proteins on tyrosine, threonine, or serine
residues (Wong 1997; Tsukamoto and Nigam 1999; Ishi-
zaki et al. 2003; D’Souza et al. 2005), and reversible
phosphorylation is shown to be crucial for regulation of TJ
assembly or maintenance (DeMaio et al. 2001).
To assess ultrastructural differences of TJ architecture,
which are not reflected by expression patterns of crucial TJ
constituents, we further applied electron microscopy of
parenchymal as well as meningeal arteries, capillaries, and
veins. Here, we focused on the aspect of TJ tightness and
evaluated whether or not qualitative differences in the
occlusion of the intercellular cleft as shown for peripheral
vessels (Fig. 1b) are detectable along the vasculature of
meninges and the neuropil. Of note, each of the analyzed
parenchymal and meningeal vessels exhibited occluded
interendothelial clefts, irrespective of its position in the
vascular tree (Fig. 3). Since evident ultrastructural differ-
ences between TJs of meningeal and parenchymal vessels
were not detected, we further investigated whether there
are measurable differences in the lengths of endothelial TJ
overlaps, which may reflect unique features of the
respective vascular segments. In consideration of reports
that vessels of different regions in the brain exhibit dif-
ferences in the composition of surrounding leptomeningeal
layers (Zhang et al. 1990; Pollock et al. 1997), which might
determine further functional aspects, we differentiated
between cortical, striatal, hippocampal, and cerebellar
vessels to include different areas to our analyses. To avoid
artifacts in the measurement of endothelial overlaps by
tangential sectioning, we strictly focused on cross sections,
only.
Interestingly and in particular rather unexpected,
parenchymal capillary vessels regularly exhibited signifi-
cantly shorter TJ overlaps, although BBB properties are
believed to be most pronounced in the capillary segment
(Fig. 4a). As secreted astroglial factors (Bauer and Bauer
2000; Abbott 2002; Haseloff et al. 2005; Utsumi et al.
2000; Abbott et al. 2006; Alvarez et al. 2011) should be
equally available for parenchymal and meningeal
endothelial cells irrespective of their position in the vas-
cular segments, direct contact of endothelial cells to
astrocytes at the glial basement membrane is only provided
in capillaries and smaller venules of the brain parenchyma,
which are not surrounded by PVS. Since the observed
differences of endothelial overlaps were absent in menin-
geal vessels at all (Fig. 4a), the possibility of an out-
standing role of the direct contact to astrocytic endfeet, in
contrast to secreted factors, is questionable. On the other
hand, secreted molecules could be trapped, modified, or
cleaved by non-cellular components of the NVU, i.e.,
basement membranes or matrix metalloproteinases, all of
which are likely to limit effects of secreted factors with
increasing distance to endothelial cells (Rundhaug 2005;
Obermeier et al. 2013). However, when grouping the
analyzed vessels into categories acknowledging either the
direct contact of endothelial cells to astrocytes, smooth
muscle cells or perivascular spaces the differences of TJ
overlaps failed to reach statistical significance (Fig. 4b).
This may be explained by the fact that endothelial contacts
to the astroglial basement membrane are not only present in
capillaries, but also post-capillary venules and smaller
veins which are not yet surrounded by a tunica media of
smooth muscle cells (Dyrna et al. 2013).
Moreover, it is important to note that the overlaps
between adjacent parenchymal endothelial cells in capil-
laries appear to be significantly shorter compared to
arteries in each of the analyzed regions and compared to
veins of the cerebral cortex, although the BBB character-
istics are usually believed to be most pronounced at the
capillary level. In fact, this would imply a negative cor-
relation between endothelial tightness and endothelial
overlaps. Notably, it seems unlikely that the described
differences between the capillary and the arterial segment
relate to fixation-related artifacts of tissue shrinking or
constriction of smooth muscle cells surrounding arterial
vessels, as this would inevitably have the same effects on
meningeal arteries, which constantly revealed comparable
distances of TJ overlaps compared to meningeal capillaries
(Fig. 4a).
To address whether other BBB-typical endothelial fea-
tures can be correlated with different segments of the
vascular tree, we analyzed endothelial cells of the brain
parenchyma and the meninges for the presence of cyto-
plasmic vesicles as a correlate for transendothelial per-
meability (Kaur and Ling 2008; Nag et al. 2011). Indeed,
the observation that endothelial vesicles appear to be rather
rare in CNS vessels when directly compared to endothelial
cells of peripheral vessels was already made by Reese and
Karnovsky (1967), who considered that the paucity of
endothelial vesicles may also explain the outstanding bar-
rier function of CNS vessels (Reese and Karnovsky 1967).




observed in the capillary segment, whereas no significant
differences to veins were detectable (Fig. 5b). In contrast,
arteries consistently revealed significantly higher amounts
of endothelial vesicles per micrometer of vascular cir-
cumference throughout the brain, with highest densities
being found in the meningeal arteries. Of note, these
findings are in line with reports suggesting a predominant
role of macromolecular transendothelial transport for pre-
capillary arterioles in a model of ultrasound-induced BBB
breakdown (Sheikov et al. 2006). In the present study, the
highest densities of transendothelial vesicles are thus found
in vessels in which direct astroglial contacts to endothelial
cells are impeded by presence of vascular smooth muscle
cells and additional layers of vascular basement mem-
branes (Dyrna et al. 2013; Zlokovic 2008; Bechmann et al.
2007). Given the fact that capillaries and smaller venous
vessels share the feature of a direct endothelial contact
towards the astroglial basement membrane, the critical
influence of astrocytes restricting transcellular, in contrast
to intercellular permeability, as indicated by lower densi-
ties of endothelial vesicles, has to be considered. Thus,
with increasing distance from astrocytic endfeet and
astrocytes-related factors, expression of permeability-re-
lated proteins, such as plasmalemmal vesicle-associated
protein-1 (PLVAP-1) and caveolin-1 (Cav-1), may be less
efficiently suppressed in arterial and meningeal endothelial
cells. On the other hand, astrocytes are known to be a major
source of vascular endothelial growth factor (VEGF),
which promotes endothelial PLVAP-1 and Cav-1 expres-
sion, thereby increasing transendothelial permeability and
endothelial vesicle counts (Kaur et al. 2006; de Bock et al.
2016). On the other hand, the lower vesicle counts in the
capillary segment may be explained by more pronounced
pericyte-endothelial interactions, as the pericyte coverage
is highest in capillaries, while arteries show a continuous
layer of smooth muscle cells, instead (Krueger and Bech-
mann 2010). In fact, PLVAP-1 has been shown to be
upregulated in pericyte-deficient transgenic mice lacking
platelet-derived growth factor receptor beta (Pdgfrb) sig-
naling, thereby leading to increased transendothelial per-
meability and vesicle counts (Armulik et al. 2010;
Daneman et al. 2010).
To the best of our knowledge, this is the first study
systematically addressing the BBB-typical endothelial
specification along the vascular tree of the brain’s par-
enchyma and within the meninges. Unexpectedly, we found
classical markers, such as occludin, ZO-1, claudin-3, and
claudin-5, to be equally distributed in all vascular segments,
including those of the subarachnoid space and thus irre-
spective of direct contact of astrocytes. Ultrastructural
investigation revealed more endothelial vesicles in arteries
and shorter TJs in capillaries. These data can now be used to
address site-specific changes in various pathologies known
to impact on BBB function (reviewed by Obermeier et al.
2013; Daneman 2012; del Zoppo 2010; Engelhardt and
Sorokin 2009; Zlokovic 2008).
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Abstract The concept of a blood-brain barrier (BBB) dates
back to experiments performed by Paul Ehrlich. Using “in-
travital tracers” which change their color depending on their
oxidative state, he intended to estimate the oxygen con-
sumption of the bodily organs. An important prerequisite
of this approach, however, would have been an equal distri-
bution of these tracers at the beginning of the experiment,
but this was not what he found: Hydrophilic dyes uniformly
did not reach the parenchyma, which led his student, the
Berlin physician Lewandowski to claim that the capillary
wall provides a barrier for certain molecules in the brain, but
it was not before the golden era of electron microscopy that
Reese and Karnovsky detected what they called “morpho-
logical barriers” of the BBB. In this article, we provide an
overview of what maintains barrier function for blood-
molecules, clarify that a BBB for solutes is neither mecha-
nistically equal to a barrier for immune cells nor in regard to
the sites of entry (capillaries versus post-capillary venules),
formulate areas of lack of knowledge and consequently,
raise open questions to be addressed in the future.
Keywords BBB .Blood-brainbarrier .Tight junctions .Glia
limitans . Basement membranes
Morphological correlates of the BBB
Molecules which are to enter the CNS have to surpass the
vascular wall, which is comprised of endothelial cells,
pericytes, if present also smooth muscle cells and a variety of
basement membranes (Fig. 1). Indeed, for some hydrophilic
molecules which are shown to penetrate peripheral vessels, the
vasculature of the CNS represents an insurmountable obstacle.
In 1885, the Berlin physician Paul Ehrlich for the first time
described the observation of a BBB as he noted that after
intravenous injection of intravital dyes the brain and spinal cord
remained white as snow while peripheral organs were readily
stained (Ehrlich 1885). Fifteen years later, Lewandowski cor-
rectly concluded that “brain capillaries must hold back certain
molecules” from entering the brain (Lewandowski 1900). Yet,
it was unclear which properties rendered the cerebral vascula-
ture outstanding in regard to its barrier function. Finally, with
the event of electron microscopy Reese and Karnovsky dem-
onstrated that the morphological correlate of the endothelial
barrier is constituted by continuous belts of tight junctions (TJ)
between adjacent overlapping endothelial cells (Fig. 2). Here,
the intercellular gap is sealed to sufficiently prevent paracellular
leakage. Although endothelial TJ are also present in the vascu-
lature of peripheral organs, the authors verified differences of
the intercellular distance of cardiac and cerebral TJ and pro-
posed a negative correlation between intercellular distance and
tightness (Reese and Karnovsky 1967).
So far, the dynamics of the regulation of these sealing
complexes is still not completely understood and thus remains
subject of further investigation, even though the molecular
constituents have been studied excessively. The knowledge of
the molecular composition of TJ has thus become more and
more complex. Their elements can be divided into integral
membrane proteins and connector or anchoring proteins
(Fig. 3, Table 1). Members of the integral group like occludin
and the claudin-family were discovered first, are well studied
and categorized by now, while the members of the junction
adherence molecule (JAM-) group and the endothelial cell-
selective adhesion molecule (ESAM) group, which both be-
long to the Ig-superfamily were characterized more recently.
In addition, the connector proteins can be divided into two
subgroups, one directly interacting with the integral proteins
like zonula occludens (ZO) ZO-1, ZO-2 and ZO-3, and the
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ones, which are indirectly associated with integral proteins.
Representatives of this group are for example cingulin,
paracingulin and junction-associated coiled-coil protein
(JACOP). Altogether, TJ complexes represent a dynamic net-
work of interacting proteins (Furuse et al. 1993, 1994;
Wolburg and Lippoldt 2002).
Fig. 1 Schematic overview of the topography of the neurovascular unit
in different segments of the vascular tree. a In capillary vessels, the
vascular wall consists of endothelial cells (yellow) and discontinuous
pericytes (green), only. The outer vascular basement is fused with the
glial basement membrane (fused gliovascular membrane color-coded in
grey) thereby occluding the perivascular space. b In post-capillary ve-
nules, the vascular wall consists of endothelial cells (yellow) and, if
present, also pericytes or smooth muscle cells of the tunica media. In
venous vessels with a diameter smaller than 30 μm, the media can also be
discontinuous or even lacking. The perivascular space often separates the
glial basement membrane from the outer vascular basement membrane. c
In arteries or arterioles, the media is formed by a single or numerous
layers of smooth muscle cells (green). Again, a perivascular space is
usually separating the glial basement membrane from the outer vascular
basement membrane covering the tunica media. The dashed black line (b
and c) illustrates the pial layer of leptomeningeal mesothelial cells, which
is thought to be discontinuous. Moreover, it is currently unclear at which
level of the vascular tree the pial sheath terminates. PVS = perivascular
space; astrocytic endfeet color-coded in blue; microglial endfeet color-
coded in purple
Fig. 2 Ultrastructural images of parenchymal vessels (a and b) and
meningeal vessels inside the subarachnoid space (c and d). The TJ
complexes are regularly found in capillary (b and d) as well as in non-
capillary vessels, which can be distinguished by diameter and addi-
tional layers of smooth muscle cells (a and c). e = endothelium;




The first discovered (Furuse et al. 1993) and most acknowl-
edged TJ protein with a molecular weight of 65 kDa was the
transmembrane protein named occludin, which is character-
istically highly expressed in the endothelium of CNS vessels
(Hirase et al. 1997). It is composed of four transmembrane
domains, three cytoplasmic domains, two extracellular do-
mains and the intracellular C- and N-termini (Feldman et al.
2005). With the cytoplasmic C-terminus, occludin has the
capability to bind the GK domain of the accessory proteins
ZO-1 and ZO-2 which ensures connection to the cytoskele-
ton (Fanning et al. 1998). Furthermore, occludin has various
sites for serine and threonine phosphorylation which is
probably involved in cell membrane linkage and TJ perme-
ability (Sakakibara et al. 1997). An overexpression of
occludin is shown to result in decreased paracellular perme-
ability (Huber et al. 2001) and a higher transendothelial
resistance (Persidsky et al. 2006). Therefore, originally
occludin was suggested to play a crucial role in the formation
and function of TJ complexes, but interestingly recent studies
revealed that occludin-deficient mice develop normal TJ
strands and regular transendothelial resistance, which may be
possible by a compensatory expression and function of other
integral proteins (Saitou et al. 2000) In addition, a variety of
data suggests a role for occludin as a regulator of epithelial cell
differentiation and signal transduction (Erickson et al. 2007;
Zlokovic 2008). Due to the ability to be vitally regulated by
phosphorylations on Ser/Thr or Tyr-residues occludin has a
more controlling rather than establishing function in TJ. While
Tyr-phosphorylations are associated with disturbtion, Ser/Thr
phosphorylation could be necessary for establishing TJ
(Sakakibara et al. 1997; Rao 2009).
Claudin
The claudin family counting 24 members with a molecular
weight of 20–27 kDa consists of four transmembrane domains
similar to occludin but without any similarities in sequence and
homology, further an intracellular carboxy tail and two extra-
cellular loops which can bind other claudins by forming dimers
(Huber et al. 2001). In addition, the intracellular C-terminus is
capable to bind a specific domain of the ZO proteins, the PDZ-
1 domain (Hawkins and Davis 2005). Often, cells expressing
claudins exhibit a repertoire of more than two isoforms there-
fore allowing different TJ sizes depending on the particular
requirements of the tissue. The claudins expressed in brain
endothelial cells are Claudin-1, -2, -3, -5, -11 and -12
(Cardoso et al. 2010). It has been shown that an overexpression
of claudin in fibroblast transfectants results in cell aggregation
and TJ-like formation in vitro, which suggests a role in
establishing TJ-specific cell contacts (Kubota et al. 1999).
Furthermore, Nitta and coworkers (Nitta et al. 2003) demon-
strated in tracer experiments, that claudin-5 knockout mice
have a size-selective permeability for certain molecules with
a molecular weight smaller than 800 Da. Concluding, claudin-
5 has an important role in establishing the paracellular barrier,
probably together with other members of the claudin family
like claudin-1 and -12 (Nitta et al. 2003; Liebner et al. 2000)
making the claudin family responsible for permeability
restriction.
Immunoglobulin-like proteins at tight junctions
The Junctional Adhesion Molecules (JAM-A,-B,-C) are
known as the first identified members of the Ig superfamily
found in TJ. JAM-A is localized at endothelial and epithelial
cell–cell contacts (Martìn-Padura et al. 1998) while JAM-B
and JAM-C are characteristic for endothelial cells only
(Aurrand-Lions et al. 2000). This family with a molecular
weight of 40 kDa consists of an intracellular tail, an extra-
cellular part consisting of two Ig-like loops and a single
transmembrane chain (Martìn-Padura et al. 1998). The JAM
proteins are suggested to be a regulator of leukocyte-
endothelial cell interaction in case of inflammation (Johnson-
Léger and Imhof 2003;Muller 2003; Ebnet et al. 2004). To this
end, the detailed role of the JAM family for proper BBB
function still needs further investigation.
Cytoplasmic accessory proteins
The first described cytoplasmic component anchoring TJ
proteins was ZO-1, a phosphoprotein with a molecular mass
of 220 kDa (Stevenson et al. 1986). It is formed by a single
GK (guanylyl kinase) domain, three PDZ (post synaptic
density protein (PSD95), Drosophila disc large tumor sup-
pressor (Dlg1), and ZO-1 protein) domains and one SH3
(SRC Homology 3) domain, which is important in signal
transduction. With its GK domain it is linked to occludin
and catalyses ATP-dependent transformation of GMP to
GDP, with its PDZ-1 domain ZO-1 is associated to
claudin-5 and with PDZ-2 and-3 to the JAM family (Shin
and Margolis 2006; Liu et al. 2012). By the intracellular C-
terminus ZO-1 is connected to the cytoskeleton as it binds
actin filaments and thereby ensures TJ function and dura-
bility (Fanning et al. 1998). Furthermore, it has been found
in adherens junctions (Itoh et al. 1993) as well as in gap
junctions (Toyofuku et al. 1998). A dissociation of ZO-1
from the junctional complex often results in an increased
permeability thereby underlining its critical function in the
molecular architecture (Abbruscato et al. 2002; Fischer et al.
2002). Another cytoplasmic protein is the 160 kDa phos-
phoprotein ZO-2, which exhibits a high sequence homology
to ZO-1 (Gumbiner et al. 1991). This protein is, however,
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rather underinvestigated, but it has been shown that it is also
linked to the TJ strands and furthermore involved in signal-
ing of transcription factors. In 2004, Umeda (Umeda et al.
2004) and colleagues were able to demonstrate that in cul-
tured epithelial cells lacking ZO-1, ZO-2 may replace ZO-1
to form morphologically regular TJ unless the functional
replacement may need to be determined. The protein ZO-3
is a member of the family, which is currently believed to be
not expressed at the BBB (Inoko et al. 2003).
Dynamic aspects of a BBB
The BBB as a specialized. regulatory interface,
not an absolute barrier
To maintain proper neuronal function, the CNS is securely
sealed to provide a stable neuronal milieu, which is not easily
affected by peripheral changes under physiological condi-
tions. However, the current concept of BBB function is
shifting from a static view to a dynamic regulatory process
which acknowledges the necessity to meet the demands of the
whole organism. For example, the concentration of potassium
in the mammalian plasma is 4.5 mM, but is fairly variable
after physical exercise, after meals and during pathology. In
contrast, the concentration of potassium in the CSF is signif-
icantly lower and maintained at 2.5–2.9 mM (Bradbury et al.
1963; Hansen 1985). Furthermore, Ca2+, Mg2+ and pH need
strict and active regulation at the BBB and the brain-
cerebrospinal fluid barrier (BCSFB) to ensure precise neuro-
nal activity.
In continuation, the plasma contains high concentra-
tions of the excitatory amino acid glutamate, which may
cause neuroexcitatory damage upon uncontrolled release
into the CSF as shown for the course of ischemic
stroke. As peripheral and central nervous system often
Fig. 3 Molecular organization
of endothelial TJ at the blood-
brain barrier. The molecular
composition of TJ is divided
into two groups: the integral
(occludin, claudin, IG-
superfamily) and the anchoring
proteins. These connector
proteins can be separated into
two subgroups with a direct
(ZO-1, 2, 3) or indirect
(cingulin, paracingulin,
JACOP) association to the
integral proteins. The
cytoplasmic anchors are linked
to the cytoskeleton (actin)
Table 1 Details of the molecular composition of TJ constituents
Occludin Claudin JAM ZO-1
Group Integral Integral Integral Cytoplasmic
Members / 24 3 3
Molecular
weight
65 kDa 20–27 kDa 40 kDa
Domains 4 transmembrane 4 transmembrane 1 intracellular tail PDZ-1
3 cytoplasmic 1 intracellular tail 1 extracellular tail with 2
Ig-like loops
PDZ-2





Features Interaction with GK-
domain of ZO-1






Extracellular loops can bind other claudins
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use the same neurotransmitters, the BBB also prevents
non-meaningful cross-talk (Abbott et al. 2006; Bernacki
et al. 2008). But also larger molecules as for example
pro-thrombin and plasminogen, which can be activated
within the CNS, may show detrimental effects to neural
tissue consequently leading to apoptosis, glial activation
and seizures (Nadal et al. 1995; Gingrich and Traynelis
2000). In addition, the BBB is shielding the CNS
against neurotoxins including proteins, xenobiotics and
endogenous metabolites. For this purpose, at the endo-
thelial level a variety of ATP-binding cassette trans-
porters actively pump respective agents out of the brain.
As a consequence of this specialization, the BBB also
exhibits low permeability to required hydrophilic nutrients
and metabolites. To ensure supply of these substances spe-
cific transport systems are expressed at the BBB as endo-
thelial TJ exclude passage of hydrophilic molecules larger
than 2–4 Å (Ohno et al. 1978; Bouldin and Krigman 1975).
In contrast, a variety of lipid-soluble molecules can read-
ily overcome the BBB and enter the CNS passively by
diffusion (Liu et al. 2004). Factors as the tendency to estab-
lish hydrogen bonds, the presence of rotatable bonds and a
large polar surface usually prevent entry into the CNS.
However, there are many substances, which do not comply
with these indicators of penetration (Bodor and Buchwald
2002). Factors as positive charges, usually shown by bases
in contrast to acids, may facilitate entrance of molecules by
interaction with negative charges on the luminal endothelial
surface, such as the glykocalyx (Abbott et al. 2010).
Nevertheless, endothelial cells express a broad spectrum of
solute carriers (SLCs) as most of the polar molecules such as
glucose and amino acids do not have free access to the CNS.
These transporters not only differ with respect to the affinity
of the addressed molecules but also in regard to their loca-
tion on the luminal or abluminal membrane, which deter-
mines direction of transport as influx or efflux transporters
(Betz et al. 1980; Begley 1996; Roberts et al. 2008). As
these characteristics are essential to maintain adequate trans-
port of solutes with regard to the intended direction, the
belts of TJ may also function as fences to segregate transport
proteins and lipid rafts to luminal or abluminal membranes.
As a large number of hydrophilic macromolecules like
proteins are physically unable to cross the endothelial layer
in a paracellular manner, the endothelium utilizes numerous
specific and unspecific transcytotic mechanisms to pave the
way for these molecules into the CNS. These vesicle-
mediated mechanisms involve receptor-mediated
transcytosis and adsorptive-mediated transcytosis (Abbott
et al. 2010). Here, after internalization of the molecules it
is necessary for transcytosis to avoid the lysosomal pathway,
which may be an additional specialization of the BBB
endothelial cells, as this bypass of the lysosomal compart-
ment is not common to peripheral endothelia (Nag and
Begley 2005). Vice versa, with regard to the general barrier
function of central endothelia the specialized uptake of
macromolecules may represent an evident need, such as to
ensure an ample nutrition. However, most ultrastructural
studies depicting cerebral vessels indicate, if detectable at
all, only few numbers of transcytotic vesicles (Reese and
Karnovsky 1967). This putative contradiction may be
explained by the fact that the ability for transcytosis of
proteins cannot be correlated with numbers of vesicles ob-
served by electron microscopy (Claudio et al. 1989).
Furthermore, cerebral endothelial cells are thin cells of only
500 nm thickness or less. Therefore, endocytotic vesicles of
50–80 nm in diameter are difficult to trap using routine
embedding procedures for electron microscopy (Abbott et
al. 2010). Smaller peptides are often internalized by
unspecific endocytosis of the fluid phase or by peptide-
specific transporter proteins similar to solute transporters
(Kastin and Pan 2003; Dogrukol-Ak et al. 2009).
A lot of molecules showing lipophilic properties poten-
tially enabling them of passive permeation of the BBB
nevertheless exhibit unexpected low penetration rates. This
observation may be explained by the presence of ABC
transporters which effectively efflux a broad spectrum of
molecules (Begley 2004). Thus, the strategy to design
CNS drugs exhibiting high lipid solubility may turn
out to be counterproductive as it increases the probabil-
ity that the drug indeed will not sufficiently reach the
brain parenchyma. Human ABC transporters represent a
protein family of 48 members being grouped into seven
sub-families (Dean et al. 2001). Under consumption of
ATP, these transporters actively release diverse lipid-
soluble substances including endogenous as well as
xenobiotic molecules and drugs. In addition to this
endothelial barrier, ABC transporters are also reported
to be expressed on pericytes and astrocytic endfeet,
which may act as a preformed second line of defence
(Shimizu et al. 2008; Wolburg et al. 2009).
Regulation of the BBB
Although Reese and Karnovsky described TJ to constitute the
morphological correlate of a BBB, it was not clear which
factors rendered endothelial cells of the CNS outstanding in
regard to this barrier function. Indeed, TJ complexes are
common for all peripheral epithelial cells, including endothe-
lial cells of peripheral vessels. Originally, astrocytes were held
responsible for the induction of these BBB properties (Janzer
and Raff 1987; Stewart andWiley 1981; Arthur et al. 1987). In
these studies, the authors succeeded in demonstrating that
under the influence of astrocytes the transendothelial resis-
tance is significantly increased. However, non-capillary endo-
thelial cells are lacking a direct astrocytic contact (Figs. 1 and
4) and furthermore, this concept leaves open the intriguing
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question of the mechanism for meningeal vessels (Fig. 5) and
vessels within subarachnoid spaces to exhibit BBB properties,
which also do not possess direct contact to astrocytic endfeet
or their associated basement membrane. Furthermore, also
parenchymal, non-capillary endothelial cells are lacking a
direct astrocytic contact. Moreover, later studies demonstrated
the establishment of BBB-typical TJ complexes in the absence
of astrocytes (Jaeger and Blight 1997; Felts and Smith 1996).
In addition to the importance of an astrocytic influence on
proper BBB function, pericytes are now regarded as key
modulators of the BBB and the neurovascular unit (NVU).
This concept finds support in data showing that also an
addition of pericytes to cultured endothelial cells is leading
to an augmented transendothelial resistance (Dente et al.
2001). The importance of pericytes for BBB formation and
maintenance is further shown by studies using mice lacking
PDGF-β or its receptor. These mice exhibit pericyte-depleted
vessels, which is demonstrated to lead to hemorrhages and
neonatal lethality. Furthermore, recently Daneman and co-
workers were able to show the impact of pericytes on BBB
formation in the development even before the astrocytic in-
fluence is established and thereby control formation of TJ and
transendothelial vesicle traffic (Daneman et al. 2010). It is
important to note, that pericyte-deficient mice do not lack
expression of BBB-associated genes. They rather fail in
downregulating genes responsible for vascular leakage, such
as ANG-2 and plasmalemma-asscociated protein. Thus,
pericytes actively suppress genes increasing vascular perme-
ability or infiltration of blood-derived leukocytes (Armulik et
al. 2010; Li et al. 2011; Daneman et al. 2010). This critical
influence is importantly not restricted to embryogenesis, but
rather a dynamic process which lasts throughout aging. Age-
dependent pericyte loss goes thus in line with a progressive
reduction of crucial TJ proteins such as occludin, claudin-5
and ZO-1 (Bell et al. 2010). As a consequence, increased
paracellular leakage may well contribute to subsequent accu-
mulation of vasculotoxic and neurotoxic blood-derived mole-
cules in the vascular wall or adjacent perivascular spaces,
which is currently believed to reduce microvascular perfusion
and therefore result in secondary neurodegeneration (Bell et
al. 2010; Winkler et al. 2011).
Vascular integrity is further demonstrated to depend on
sphingosine-1-phosphate signalling (S1P), which comprises
the expression of N-cadherin and VE-cadherin in endothe-
lial cells (Armulik et al. 2005). These factors are expressed
upon binding of S1P to its receptor (Paik et al. 2004). VE-
cadherin is component of inter-endothelial junctions
while N-cadherin is engaged in forming peg-socket con-
tacts between endothelial cells and pericytes. Interfering
with S1P signalling regularly results in decreased pericyte
Fig. 4 Parenchymal vessels: a
and b Analysis of vessels with
different diameters reveals
presence of TJ proteins in CNS
vessels of every diameter. c The
TJ within the endothelium are
demarked by co-stainings for
CD31 and laminin. d Double
labelling for claudin-5 and
alpha-SMA clearly
demonstrates TJ in non-
capillary vessels. Note that the
layer of alpha-SMA positive
smooth muscle cells (red)
physically inhibits direct
contact between astrocytic
endfeet of the glia limitans and
the endothelium. SMA = smooth
muscle actin; CD31 =
endothelial marker; Laminin =
marker for vascular basement
membranes
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and smooth muscle cell coverage of blood vessels, again
leading to vascular abnormalities and neonatal lethality
(Liu et al. 2008).
Given that the NVU is a rather complex structure and
maintenance of the unique neuronal milieu is vitally impor-
tant, it may not be surprising to find that induction of BBB
properties is depending on more than one distinct cell type.
The juxtavascular endfeet of astrocytes are moreover in an
ideal position to provide endothelial signalling in the capil-
lary segment. This astrocyte-endothelial signalling in-
volves transforming growth factor-β (TGF-β), glial-
derived neurotrophic factor (GDNF), basic fibroblast
growth factor (bFGF) and angiopoietin 1 (ANG-1),
which binds to the endothelium-specific receptor TIE2
all of which lead to increased transendothelial resistance
in vitro (Igarashi et al. 1999; Lee et al. 2003). Vice
versa, the endothelial-derived factor LIF has been dem-
onstrated to induce astrocytic differentiation (Mi et al.
2001). Moreover, as astrocytes are interlinked between
neurons and the capillary endothelium, they are situated
in a strategic position to influence and ensure the neu-
ronal microenvironment. As neuronal activity leads to
release of potassium, an increase of intercellular K+ is
buffered by uptake into parenchymal astrocytic endfeet,
while it is released over juxtavascular processes via the
K+ channel Kir4.1 thereby creating a spatial buffering
system (Price et al. 2002; Kofuji and Newman 2004).
Furthermore, K+ uptake of astrocytes by channels or
ATP-dependent transporters consequently results in os-
motic water uptake. As this mechanism would lead to cel-
lular swelling, also the water needs to be redistributed, which
involves aquaporin 4 (AQP4) water channels on juxtavascular
astrocytic endfeet (Abbott et al. 2006). Here, excess metabolic
water joins the CSF, which drains along vascular basement
membranes and arachnoid granulations. However, AQP4 wa-
ter channels may also be detrimental to volume regulation
under pathological conditions as an upregulation was shown
to occur in situations of brain edema associated to BBB break-
down. This view can be further substantiated by the finding
that AQP4-knock-out mice are protected from ischemia-
induced brain edema (Verkman 2002).
Furthermore, astrocytes are shown to promote BBB in-
tegrity by signalling via the glycoprotein Sonic hedgehog
while respective receptors were found on endothelial cells
(Alvarez et al. 2011). The authors demonstrate that astro-
cytes not only induce and maintain BBB function during
embryonic development and adulthood, but also that this
critical influence significantly limits access of immune cells
to the CNS by downregulation of proinflammatory mole-
cules in cerebral endothelial cells.
Fig. 5 Meningeal vessels in the
subarachnoid space shown in
hole-head sections: a and b
Clearly, these subarachnoid
vessels are not in direct contact
to the glia limitans, but express
TJ proteins as confirmed by
immune labeling for claudin-5
and occludin. c and d Co-
stainings for alpha-SMA
demonstrate their presence also
in non-capillary vessels
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The Wnt/ß-catenin pathway is also demonstrated to have
the capability to regulate BBB properties in primary brain
endothelial cells (Liebner et al. 2008). In this model the
stabilization of ß-catenin via N-terminal truncation or treat-
ment with Wnt3a resulted in a higher expression of claudin-
3 in the brain vasculature and an increased TJ formation. In
contrast, a lack of ß-catenin leads to barrier breakdown
(Liebner et al. 2008). In line with these findings Daneman
and co-workers highlighted the impact of Wnt/β-catenin
signaling for CNS angiogenesis and BBB typical trans-
porters by demonstration of the critical influence on BBB-
specific transporters like glut-1 and its role in BBB forma-
tion (Daneman et al. 2009).
Is the BBB a barrier for leukocytes?
Although Ehrlich’s early description of the phenomenon of
a BBB strictly relates to hydrophilic molecules, the meta-
phor was misleadingly taken over into the context of
neuroimmunology and thus, applied for cellular trafficking.
Diffusion and transportation of molecules in one or the other
direction across the BBB is regulated at the level of capil-
laries, while recruitment of leukocytes—according to text-
book knowledge—takes place at the level of post-capillary
venules. This part of the vascular tree significantly differs
from capillaries by its layering of different cell types which
in contrast to capillaries include smooth muscle cells, but
the molecular composition of TJ in brain venules is ill-
defined. There is no proof that similar “morphological cor-
relates” maintaining a barrier for solutes also exclude leu-
kocytes. In general, it is not specific to brain vessels that
they do not allow leukocytes to freely transverse them, but a
general feature of the vasculature throughout the body,
except for some areas in the spleen. In that sense, the term
BBB in the context of immune cell recruitment is not helpful
as it suggests a brain-specific mechanical tightness, a con-
cept which is not supported by data. However, there is the
observation of limited immune surveillance of the brain
parenchyma (Murphy and Sturm 1923), but perivascular
spaces are readily targeted by at least monocytes
(Bechmann et al. 2001, 2007). Thus, the glia limitans, a
structure expressing the apoptosis-inducing protein FasL
(CD95L) (Bechmann et al. 1999) may turn out to be much
more important to exclude immune cells from entering the
neuropil and first studies demonstrating that MMP-
inhibitors put immune cells on hold in perivascular spaces
(Toft-Hansen et al. 2006) support this view.
Interestingly, the group of Alexander Flügel was re-
cently able to demonstrate that as a prerequisite for
injected autoreactive T-cells to overwhelm the BBB,
the T-cells have to become licensed in the lung
(Odoardi et al. 2012). The authors hypothesize that local
stimulation in the lung is necessary for massive prolif-
eration and acquirement of migratory properties, which
allow entering the CNS in this model of EAE.
Extracellular matrix and the role of laminins
for an immunological BBB
In this part, we therefore highlight the role of the extracellular
matrix in form of BBB-associated basement membranes and
their decisive influence on leukocyte recruitment during
neuroinflammation. On their way into the neuropil leukocytes
encounter two biochemically and functionally distinct base-
ment membranes surrounding post-capillary venules (Sixt et
al. 2001). Basement membranes represent compositions of
highly cross-linked glycoproteins. These generally consist of
one or two laminin isoforms, type IV collagen, nidogen,
perlecan and minor glycoproteins (Sorokin 2010) all of which
as a network constitute additional obstacles for traversing
leukocytes. In detail, studies on T-cell extravasation demon-
strated that passage of the endothelium usually requires 9 to
10 min while traversing the underlying basement membrane
required 30 min (Bartholomäus et al. 2009). In this context,
interactions between endothelial cells and infiltrating leuko-
cytes via CD 31 are shown to upregulate α6β1 integrin on
infiltrating neutrophils, which can act as a receptor for lami-
nin. Once this pathway is experimentally blocked, infiltrating
cells are trapped between endothelial cells and their basement
membrane (Dangerfield et al. 2002). In the CNS, endothelial
basement membranes surrounding post-capillary venules are
composed of laminin α4 and laminin α5. While laminin α4 is
ubiquitously expressed in these basement membranes, lami-
nin α5 rather shows a patchy distribution pattern (Wu et al.
2009). In an experimental animal model of multiple sclerosis
(EAE), which is characterized by massive recruitment of T
cells into the neuropil, the sites of infiltration were demon-
strated to correlate with sites of constitutive expression of
laminin α4 and low expression of laminin α5, which was
interpreted as an inhibitory effect of laminin α5 on T cell
transmigration. Furthermore, mice lacking laminin α4 but
expressing ubiquitously laminin α5 show significantly de-
creased immune cell recruitment which supports the idea of
the impact of the composition of extracellular matrix on the
immunological BBB (Wu et al. 2009). Again, to distinguish
between both laminin isoforms T cells depend on the expres-
sion of α6β1 integrin.
Interestingly, due to the complex anatomy of the
neurovascular unit, after passing the endothelial basement
membrane infiltrating leukocytes are facing another base-
ment membrane, which is formed by astrocytic endfeet of
the glia limitans. This basement membrane is biochemically
distinct, as it contains different laminin isoforms, i.e. lami-
nin α1 and laminin α2 (Sixt et al. 2001) and furthermore it
is functionally distinct as its crossing strictly depends on the
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matrix metalloproteinases MMP-2 and MMP-9, which se-
lectively cleave the dystroglycan receptor anchoring astro-
cytic endfeet to their basement membrane (Agrawal et al.
2006). This process is necessary to facilitate T cell infiltra-
tion into the neuropil, which further substantiates the impact
of basement membranes on BBB function, at least from the
immunological point of view.
Open questions
At present, three issues in BBB research seem to be
neglected the most:
1. It is apparent that the vasculature of the leptomeninges
is similarly equipped to keep out certain molecules from
penetrating the subarachnoid space. Since these vessels
are not in contact to astrocytes, it is likely that different
signals induce their differentiation. For many (clinical)
reasons, it would be helpful to understand this process.
2. The molecular composition of BBB TJ has not been
described systematically in regard to the different parts
of the vascular tree. We need to know whether arteries,
veins, and capillaries differ in the connection between
endothelial cells and their capability to keep out or
active transport molecules from the blood stream.
3. The transfer of meaning of a BBB in the context of
immune cell recruitment has caused many misconcep-
tions. The induction of the expression of adhesion mol-
ecules and chemokines in endothelial cells is driven by
cytokines and chemokines; therefore, it is likely that the
key to understand how and when immune cells are
recruited into the brain is relying on gaining insight in
what makes the respective environment and response of
brain endothelial cells to it special. In addition, we need
to better understand how the glia limitans becomes
permissive for immune cells entering from perivascular
spaces into the neuropil.
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The blood-brain barrier of central nervous system (CNS) vessels ensures the unique 
neuronal microenvironment thereby maintaining proper neuronal function. To limit 
uncontrolled access of blood-borne molecules into the CNS, specific tight junctions (TJ) 
connect adjacent endothelial cells within the BBB. Their composition has been studied 
intensively to reveal the molecular composition. Individual tight junction complexes consist of 
a cluster of molecules. Here the transmembrane proteins occludin and claudin are playing a 
vital role in the establishment and maintenance of the BBB. Occludin links the TJ complex 
via zonula occludens (ZO) molecules to the actin filaments of the cytoskeleton and appears 
to be the primary regulator. Further only specific members of the claudin family including 
claudin-3, claudin-5 and claudin-12 are part of the BBB specific TJ. The unique structural 
composition of the BBB differs between vessel types. Hence capillaries and postcapillary 
venules consist only of an endothelial monolayer intimately connected by tight junction 
complexes, whereas the vascular wall of vessels with larger diameters like arterioles and 
arteries consist of multiple cell layers including smooth muscle cells. It has been assumed 
that the close anatomical localization between astrocytes and endothelium-specific for the 
brain microvasculature influences the development of the BBB. However, this intimate 
contact is only present in brain capillaries as the endothelium is separated from astrocytic 
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endfeet by a single basement membrane, only. Therefore, the studies addressing BBB 
properties appear to be often confined to the capillary segment or rather ill-defined 
microvessels, leaving open the question whether the data obtained is equally representative 
for arteries, capillaries and veins. Further, a direct comparison involving the leptomeningeal 
blood vessels is often lacking. 
For these reasons, the present thesis addressed the following questions. 
1. How does the ultrastructural composition of endothelial cell contacts differ along the 
vascular tree of the blood-brain barrier? 
2. Are there detectable differences in the molecular composition between the TJ 
complexes in arteries, capillaries and veins? 
3.  In which way does the direct contact of endothelial cells to adjacent astrocytes affect 
the ultrastructure or the distribution of critical TJ proteins in parenchymal and 
meningeal vessels?  
For this purpose, vessels were categorized into capillaries, veins or arteries by the diameter 
and the presence or absence of surrounding smooth muscle cells of the tunica media, which 
are indicative of the arterial branch of the vascular tree, but are lacking in the veins of the 
CNS. Furthermore representative vessels from various regions of the brain and the 
leptomeninges were included. This way a comprehensive analysis of over 1000 vessels was 
performed comparing parenchymal vessels to leptomeningeal vessels in regards to 
ultrastructure and molecular composition of TJ strands. In order to preserve as the fragile 
leptomeningeal tissue for analyses of meningeal vessels, we performed whole head 
sectioning thereby avoiding the removal of the brain from skull and dura mater. Additional 
counter- and co-staining’s (smooth muscle antigen SMA, DAPI) were performed to 
distinguish between different vessel types. Further, we applied electron microscopy to 
measure and compare the length of endothelial overlaps as well as the density of endothelial 
vesicles, indicative of a transendothelial vesicle trafficking.  
In contrast to the initial assumption, we demonstrated that essential TJ proteins including 
claudin-3, claudin-5, zonula occludens-1, and occludin as typical constitutes of BBB-typical 
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TJs are comparably distributed throughout the vascular tree of parenchymal and meningeal 
vessels. However, electron microscopy revealed significant differences in the length of 
endothelial overlaps, with reproducibly longer overlaps in arteries and veins compared to 
capillaries within parenchymal vessels but not within the leptomeninges. Therefore, the 
distance to surrounding astrocytes seems not to affect the endothelial expression of BBB 
typical TJ proteins, but individual segments of the CNS vasculature display detectable 
ultrastructural differences.  
In the present study, we systematically examined and compared characteristics of the 
endothelial layer in capillary, arterial, and venous vessels of the brain parenchyma and 
leptomeninges. These data and the applied methods can now be compared and adapted to 
address alterations of the BBB in various models of CNS neuropathology. These studies may 
therefore help to develop novel therapeutic strategies to restore the BBB function in cases of 
local or global blood-brain barrier disruption. 
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